Gaurav Maini
Stock Analyst at LifeSci Capital
(0.26)
# 4,483
Out of 4,683 analysts
42
Total ratings
50%
Success rate
-17.9%
Average return
Main Sectors:
Stocks Rated by Gaurav Maini
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LQDA Liquidia | Downgraded: Hold | $101 → $90 | $70.49 | +27.68% | 6 | Aug 12, 2026 | |
| IKT Inhibikase Therapeutics | Maintained: Buy | $5 | $2.50 | +100.00% | 5 | Aug 11, 2026 | |
| TENX Tenax Therapeutics | Maintained: Buy | $35 → $5 | $2.32 | +115.52% | 9 | Aug 10, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | $60 → $6 | $6.25 | -4.00% | 12 | Aug 10, 2026 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $88 | $37.71 | +133.36% | 8 | Aug 6, 2026 | |
| CTNM Contineum Therapeutics | Maintained: Buy | $24 | $17.05 | +40.76% | 1 | Jul 31, 2026 | |
| CNTM ConnectM Technology Solutions, Inc. | Initiated Coverage: Buy | $24 | $4.60 | +421.74% | 1 | Jul 30, 2026 |
Liquidia
Aug 12, 2026
Downgraded: Hold
Price Target: $101 → $90
Current: $70.49
Upside: +27.68%
Inhibikase Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $5
Current: $2.50
Upside: +100.00%
Tenax Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $35 → $5
Current: $2.32
Upside: +115.52%
Sionna Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: $60 → $6
Current: $6.25
Upside: -4.00%
Tectonic Therapeutic
Aug 6, 2026
Reiterated: Buy
Price Target: $88
Current: $37.71
Upside: +133.36%
Contineum Therapeutics
Jul 31, 2026
Maintained: Buy
Price Target: $24
Current: $17.05
Upside: +40.76%
ConnectM Technology Solutions, Inc.
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $4.60
Upside: +421.74%